Basic Information
| LncRNA/CircRNA Name | GBCDRlnc1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | Cycloheximide,Doxorubicin,Chloroquine | |
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gallbladder cancer |
| ICD-0-3 | C23.9 |
| Methods | qPCR, Microarray, Western blot, RIP, RNAi |
| Sample | gallbladder cancer tissues,cell lines(NOZ,GBC-SD) |
| Expression Pattern | up-regulated |
| Function Description | Furthermore, we discovered that GBCDRlnc1 is upregulated in gallbladder cancer tissues. |
| Pubmed ID | 30953511 |
| Year | 2019 |
| Title | Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. |
External Links
| Links for GBCDRlnc1 | GenBank HGNC NONCODE |
| Links for gallbladder cancer | OMIM COSMIC |